Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunoprecise Antibodies Ltd
(NQ:
IPA
)
1.290
+0.030 (+2.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Immunoprecise Antibodies Ltd
< Previous
1
2
3
4
Next >
“Convergence of AI and Biology: Companies at the Forefront of Transformative Innovations”:- IPA, MRKR, PRAX , RMED
June 21, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
IPA’s Subsidiary BioStrand Unveils Use Case for Solving the Information Integration Dilemma (IID)
June 13, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
Healthcare and AI “Paradigm Shift” Stocks in Focus: IPA, MGRX, INBS, RMED
June 09, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) Is Strategically Built To Advance The Future
June 09, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
‘Baby with the Bathwater’ Biotechs (IPA, NRXP, PRFX, LEXX, LQDI)
June 01, 2022
Via
AB Newswire
IPA Releases New HYFT-Powered In Silico Humanization Platform, Aims to Disrupt the Transgenic Animal Model Market
June 06, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology
May 30, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA to Present at Jefferies Healthcare Conference 2023
May 17, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
The Street Reports: NASDAQ Stocks Poised to Disrupt the Markets: IPA, RELI, SKYX, AZ
May 03, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
TheStreetReports: AI Biotech Stocks to Watch 2023: IPA, ONTX, AGEN, PBIO
April 24, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with Astellas
March 30, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
European Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® Technology
March 27, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival Rates
March 23, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023
March 16, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera Bio
March 15, 2023
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023
March 07, 2023
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023
December 15, 2022
From
IMMUNOPRECISE ANTIBODIES LTD.
Via
Business Wire
IPA’s Subsidiary BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs™ and Accelerates in Silico Drug Discovery Developments
December 08, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022
December 05, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
November 30, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Antibodies Ltd. Announces Voluntary Delisting from TSX Venture Exchange
November 22, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA’s Subsidiary Talem Therapeutics Licenses Antibodies for Three OmniChicken-Derived Programs
October 12, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
NIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75
September 14, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023
September 14, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2023 on September 14, 2022
September 08, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Live Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope’s Efficacy Against SARS-CoV-2 Variants Including BA.5
August 29, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2022
July 29, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022
July 26, 2022
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
Histopathology Data of Preclinical Repeated Dose Toxicity Study and ex vivo Human Tissue Cross-Reactivity (TCR) Analysis Support Safety of IPA’s PolyTope® TATX-03, a Synergistic Antibody Cocktail against SARS‑CoV‑2
July 12, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
Immunity Focused Biotherapeutic Developer with a Hybrid of Services and Technology for a Wide Range of Applications: ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA)
July 07, 2022
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.